Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling

NCT01438073 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01438073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01438073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2011
Completion date
April 30, 2016
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agonadism, healthy postmenopausal women, hypogonadotropic hypogonadism